Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
News Briefing channel feed
Lilly pledges more than $650M to muscle health biotech; Cogent gets $50M
21 hours ago
Insmed’s stock rallies on PAH data; Unicycive aims to resolve CDMO issues
Yesterday
Avidity to seek accelerated approval for FSHD drug; Axsome to run another trial
2 days ago
Kelun's $250M PIPE; Valneva moves chikungunya vaccine to Phase 3 for kids
5 days ago
Cullinan's deal for T cell engager from China; Kardigan buys late-stage heart drug
6 days ago
Vigil drug fails a Phase 2; Merus aims to raise $300M
Last week
Vera redraws the terms of up to $500M credit facility; Trevi aims to raise $100M
Last week
Sanofi pays out two STAT6 milestones; Theravance sells more Trelegy royalties
Last week
Roche’s 96-week data for multiple sclerosis drug; ZymeWorks claims $20M milestone
Last week
Taysha’s pivotal trial plans; Keros to stop work on PAH drug, lay off 45% of staff
Last week
Veru’s obesity drug roughly as safe as Wegovy; Keros’ board fight
2 weeks ago
ITM reveals up to $262M debt financing; Caris Life Sciences to go public
3 weeks ago
GLP-1s may cut cancer risk; Gyre’s stock falls after hep B data and offering
3 weeks ago
Moderna pulls application for Covid-flu shot; Another IPO in Hong Kong
3 weeks ago
SV Health’s $269M dementia fund; Schrödinger lays off 7% of staff
4 weeks ago
Ionis details late-stage data for heart drug; Armata’s promising staph infection therapy
4 weeks ago
FDA lifts hold on Scynexis trial; Incyte’s Zynyz notches another FDA approval
4 weeks ago
Enliven stops work on solid tumor drug; Pulmatrix to divest assets
4 weeks ago
SK, Carlyle bolster bluebird bio bid; Therini Bio raises $39M
4 weeks ago
Axsome's $570M loan with Blackstone; Altimmune makes its own credit deal
5 weeks ago
FDA clears in vivo blood stem cell editing trial; Abeona's $155M PRV sale
5 weeks ago
AstraZeneca reports Phase 3 win for Imfinzi; Roche to build new manufacturing site in China
Last month
ALX Oncology won’t seek approval for CD47 drug in gastric cancer; Korro Bio’s layoffs
Last month
European regulators to review Valneva shot; Jazz's stock dips on subpar first-quarter revenue
Last month
1
2
3
4
Next page
Last page